I agree that this site is using cookies. You can find further informations here.
X
Mohty, M.
~ 600  results:
Search for persons X
?
1

French early nationwide idecabtagene vicleucel chimeric ant..:

Ferment, B. ; Lambert, J. ; Caillot, D....
British Journal of Haematology.  , 2024
Link: https://doi.org/10.1111/..
 
?
2

Allogeneic hematopoietic cell transplantation is equally ef..:

Sadowska-Klasa, A. ; Zaucha, J. M. ; Labopin, M....
Bone Marrow Transplantation.  59 (2024)  3 - p. 387-394 , 2024
Link: https://doi.org/10.1038/..
 
?
3

ELRANATAMAB, A B-CELL MATURATION ANTIGEN-CD3 BISPECIFIC ANT..:

Mohty, M ; Tomasson, M ; Arnulf, B...
Hematology, Transfusion and Cell Therapy.  45 (2023)  - p. S404-S405 , 2023
Link: https://doi.org/10.1016/..
 
?
4

CO52 Comparative Analysis of Tabelecleucel Versus Standard ..:

Brookhart, M.A. ; Barlev, A. ; Mohty, M....
Value in Health.  26 (2023)  12 - p. S23 , 2023
Link: https://doi.org/10.1016/..
 
?
5

PROGNOSTIC SCORING SYSTEMS FOR SEVERE CRS AND ICANS AFTER A..:

Sesques, P. ; Di blasi, R. ; Legouill, S....
Hematological Oncology.  41 (2023)  S2 - p. 202-204 , 2023
Link: https://doi.org/10.1002/..
 
?
6

Transfusion needs after CD19 CAR T‐cells for large B‐cell l..:

Vic, S. ; Thibert, J. ; Bachy, E....
Hematological Oncology.  41 (2023)  S2 - p. 534-536 , 2023
Link: https://doi.org/10.1002/..
 
?
7

EFFICACY AND SAFETY OF ELRANATAMAB IN PATIENTS WITH RELAPSE..:

Nooka, A ; Lesokhin, A ; Mohty, M...
Hematology, Transfusion and Cell Therapy.  45 (2023)  - p. S405 , 2023
Link: https://doi.org/10.1016/..
 
?
8

EFFICACY AND SAFETY OF ELRANATAMAB BY AGE AND FRAILTY IN PA..:

Raje, N ; Leleu, X ; Lesokhin, A...
Hematology, Transfusion and Cell Therapy.  45 (2023)  - p. S406-S407 , 2023
Link: https://doi.org/10.1016/..
 
?
9

P1371: GRAFT-VERSUS-HOST DISEASE OFFERS NO GRAFT-VERSUS-LEU..:

Shimoni, A. ; Peczynski, C. ; Labopin, M....
HemaSphere.  6 (2022)  - p. 1255-1256 , 2022
Link: https://doi.org/10.1097/..
 
?
10

S210: CAR T-CELLS ASSOCIATED ACUTE TOXICITY IN B-CELL NON-H..:

SESQUES, P. ; DI BLASI, R. ; LE GOUILL, S....
HemaSphere.  6 (2022)  - p. 111-112 , 2022
Link: https://doi.org/10.1097/..
 
?
11

P1355: VENO-OCCLUSIVE DISEASE/SINUSOIDAL OBSTRUCTION SYNDRO..:

Mohty, M. ; Yakoub-Agha, I. ; Dalle, J.-H....
HemaSphere.  6 (2022)  - p. 1240-1241 , 2022
Link: https://doi.org/10.1097/..
 
?
12

P949: A PHASE 2 TRIAL OF ELRANATAMAB, A B-CELL MATURATION A..:

Lesokhin, A. M. ; Arnulf, B. ; Niesvizky, R....
HemaSphere.  6 (2022)  - p. 839-840 , 2022
Link: https://doi.org/10.1097/..
 
?
13

P1339: CLINICAL OUTCOMES OF PATIENTS WITH EBV+ PTLD FOLLOWI..:

Sanz-Caballer, J. ; Storek, J. ; Socié, G....
HemaSphere.  6 (2022)  - p. 1224-1225 , 2022
Link: https://doi.org/10.1097/..
 
?
14

THE DEFIFRANCE REGISTRY STUDY: EFFECTIVENESS AND SAFETY OF ..:

Yakoub-Agha, I ; Blaise, D ; Dalle, J...
Hematology, Transfusion and Cell Therapy.  44 (2022)  - p. S297 , 2022
Link: https://doi.org/10.1016/..
 
?
15

Management of adults and children receiving CAR T-cell ther..:

Hayden, P.J. ; Roddie, C. ; Bader, P....
Annals of Oncology.  33 (2022)  3 - p. 259-275 , 2022
Link: https://doi.org/10.1016/..
 
1-15